Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology

被引:47
作者
Espinar, Maria Jose [1 ,2 ]
Miranda, Isabel M. [1 ,3 ]
Costa-de-Oliveira, Sofia [1 ,3 ]
Rocha, Rita [1 ]
Rodrigues, Acacio G. [1 ,2 ]
Pina-Vaz, Cidalia [1 ,2 ,3 ]
机构
[1] Univ Porto, Fac Med, Dept Microbiol, P-4100 Oporto, Portugal
[2] Hosp Sao Joao, Dept Clin Pathol, Oporto, Portugal
[3] Univ Porto, CINTESIS Ctr Hlth Technol & Serv Res, Fac Med, P-4100 Oporto, Portugal
关键词
AMPLIFIED POLYMORPHIC DNA; INTENSIVE-CARE-UNIT; CTX-M ENZYMES; RENAL-TRANSPLANTATION; ANTIBIOTIC-RESISTANCE; ENTEROBACTERIACEAE; RECIPIENTS; COMMUNITY; RECURRENT; BACTEREMIA;
D O I
10.1371/journal.pone.0134737
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Urinary tract infection (UTI) is a common complication after kidney transplantation, often associated to graft loss and increased healthcare costs. Kidney transplant patients (KTPs) are particularly susceptible to infection by Enterobacteriaceae-producing extended-spectrum beta-lactamases (ESBLs). A retrospective case-control study was conducted to identify independent risk factors for ESBL-producing Escherichia coli and Klebsiella pneumoniae in non-hospitalized KTPs with UTI. Forty-nine patients suffering from UTI by ESBL-producing bacteria (ESBL-P) as case group and the same number of patients with UTI by ESBL negative (ESBL-N) as control-group were compared. Clinical data, renal function parameters during UTI episodes, UTI recurrence and relapsing rate, as well as risk factors for recurrence, molecular characterization of isolates and the respective antimicrobial susceptibility profile were evaluated. Diabetes mellitus (p <0.007), previous antibiotic prophylaxis (p=0.017) or therapy (p<0.001), previous UTI (p=0.01), relapsing infection (p=0.019) and patients with delayed graft function after transplant (p=0.001) represented risk factors for infection by ESBL positive Enterobacteriaceae in KTPs. Interestingly, the period of time between data of transplantation and data of UTI was shorter in case of ESBL-P case-group (28.8 months) compared with ESBL-N control-group (50.9 months). ESBL-producing bacteria exhibited higher resistance to fluoroquinolones (p=0.002), trimethoprim-sulfamethoxazole (p<0.001) and gentamicin (p<0.001). Molecular analysis showed that bla(CTX-M) was the most common ESBL encoding gene (65.3%), although in 55.1% of the cases more than one ESBL gene was found. In 29.4% of K. pneumoniae isolates, three bla-genes (bla(CTX-M)-bla(TEM)-bla(SHV)) were simultaneously detected. Low estimated glomerular filtration rate (p=0.009) was found to be risk factor for UTI recurrence. Over 60% of recurrent UTI episodes were caused by genetically similar strains. UTI by ESBL-producing
引用
收藏
页数:11
相关论文
共 40 条
[1]   Late urinary tract infection after renal transplantation in the United States [J].
Abbott, KC ;
Swanson, SJ ;
Richter, ER ;
Bohen, EM ;
Agodoa, LY ;
Peters, TG ;
Barbour, G ;
Lipnick, R ;
Cruess, DF .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (02) :353-362
[2]   Urinary tract infections in kidney transplant recipients: Role of gender, urologic abnormalities, and antimicrobial prophylaxis [J].
Ariza-Heredia, Ella J. ;
Beam, Elena N. ;
Lesnick, Timothy G. ;
Kremers, Walter K. ;
Cosio, Fernando G. ;
Razonable, Raymund R. .
ANNALS OF TRANSPLANTATION, 2013, 18 :195-204
[3]   Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit [J].
Bagattini, M ;
Crivaro, V ;
Di Popolo, A ;
Gentile, F ;
Scarcella, A ;
Triassi, M ;
Villari, P ;
Zarrilli, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (05) :979-982
[4]   Impact of Antibiotic Resistance on the Development of Recurrent and Relapsing Symptomatic Urinary Tract Infection in Kidney Recipients [J].
Bodro, M. ;
Sanclemente, G. ;
Lipperheide, I. ;
Allali, M. ;
Marco, F. ;
Bosch, J. ;
Cofan, F. ;
Ricart, M. J. ;
Esforzado, N. ;
Oppenheimer, F. ;
Moreno, A. ;
Cervera, C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (04) :1021-1027
[5]   Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[6]   SHV-7, A NOVEL CEFOTAXIME-HYDROLYZING BETA-LACTAMASE, IDENTIFIED IN ESCHERICHIA-COLI ISOLATES FROM HOSPITALIZED NURSING-HOME PATIENTS [J].
BRADFORD, PA ;
URBAN, C ;
JAISWAL, A ;
MARIANO, N ;
RASMUSSEN, BA ;
PROJAN, SJ ;
RAHAL, JJ ;
BUSH, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) :899-905
[7]   Epidemiological Expansion, Structural Studies, and Clinical Challenges of New β-Lactamases from Gram-Negative Bacteria [J].
Bush, Karen ;
Fisher, Jed F. .
ANNUAL REVIEW OF MICROBIOLOGY, VOL 65, 2011, 65 :455-478
[8]   Plasmids and the spread of resistance [J].
Carattoli, Alessandra .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 303 (6-7) :298-304
[9]  
CLSI, 2011, M100 CLSI
[10]  
Coque TM, 2008, EURO SURVEILL, V13